CN1287795C - 阿昔莫司分散片剂型 - Google Patents
阿昔莫司分散片剂型 Download PDFInfo
- Publication number
- CN1287795C CN1287795C CN 200410057365 CN200410057365A CN1287795C CN 1287795 C CN1287795 C CN 1287795C CN 200410057365 CN200410057365 CN 200410057365 CN 200410057365 A CN200410057365 A CN 200410057365A CN 1287795 C CN1287795 C CN 1287795C
- Authority
- CN
- China
- Prior art keywords
- acipimox
- dispersible tablet
- dispersible
- disintegrating agent
- prescription
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
时间(min) | 5 | 10 | 15 | 20 | 25 | 30 |
累积溶出度(%) | 43 | 52 | 65 | 74 | 83 | 91 |
分散时限 | 3.0min崩解,并可全部通过2号筛 |
时间(min) | 5 | 10 | 15 | 20 | 25 | 30 |
累积溶出度(%) | 46 | 57 | 68 | 79 | 85 | 93 |
分散时限 | 2.8min崩解,并可全部通过2号筛 |
时间(min) | 5 | 10 | 15 | 20 | 25 | 30 |
累积溶出度(%) | 51 | 60 | 71 | 81 | 89 | 94 |
分散时限 | 2.5min崩解,并可全部通过2号筛 |
时间(min) | 5 | 10 | 15 | 20 | 25 | 30 |
累积溶出度(%) | 53 | 64 | 73 | 80 | 90 | 94 |
分散时限 | 1.9min崩解,并可全部通过2号筛 |
时间(min) | 5 | 10 | 15 | 20 | 25 | 30 |
累积溶出度(%) | 55 | 67 | 78 | 89 | 92 | 95 |
分散时限 | 1.5min崩解,并可全部通过2号筛 |
时间(min) | 5 | 10 | 15 | 20 | 25 | 30 |
累积溶出度(%) | 70 | 81 | 88 | 92 | 96 | 97 |
分散时限 | 1.0min崩解,并可全部通过2号筛 |
时间(min) | 5 | 10 | 15 | 20 | 25 | 30 |
累积溶出度(%) | 79 | 89 | 91 | 93 | 96 | 98 |
分散时限 | 0.8min崩解,并可全部通过2号筛 |
时间(min) | 5 | 10 | 15 | 20 | 25 | 30 |
累积溶出度(%) | 91 | 93 | 97 | 98 | 99 | 99 |
分散时限 | 0.1min崩解,并可全部通过2号筛 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410057365 CN1287795C (zh) | 2004-08-30 | 2004-08-30 | 阿昔莫司分散片剂型 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410057365 CN1287795C (zh) | 2004-08-30 | 2004-08-30 | 阿昔莫司分散片剂型 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1628669A CN1628669A (zh) | 2005-06-22 |
CN1287795C true CN1287795C (zh) | 2006-12-06 |
Family
ID=34846199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410057365 Active CN1287795C (zh) | 2004-08-30 | 2004-08-30 | 阿昔莫司分散片剂型 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1287795C (zh) |
-
2004
- 2004-08-30 CN CN 200410057365 patent/CN1287795C/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN1628669A (zh) | 2005-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1799543A (zh) | 替米沙坦分散片及其制备方法 | |
CN1254246C (zh) | 西地那非及其药学上可接受的盐的口腔崩解片及其制备方法 | |
CN1287795C (zh) | 阿昔莫司分散片剂型 | |
CN1287792C (zh) | 孟鲁司特钠的分散片剂型 | |
CN1806805A (zh) | 一种氯氮平口腔崩解片及其制备方法 | |
CN1864679A (zh) | 一种复方岩白菜素分散片及其制备方法 | |
CN1443535A (zh) | 马来酸替加色罗口服制剂及其制备工艺——治疗肠易惹综合征 | |
CN1247202C (zh) | 薯蓣皂苷口腔崩解片及其制备方法 | |
CN1323667C (zh) | 三七分散片及其制备方法 | |
CN1250228C (zh) | 三七总皂苷口腔崩解片及其制备方法 | |
CN1839847A (zh) | 盐酸替扎尼定口腔崩解片及其制备方法 | |
CN1283267C (zh) | 人参茎叶总皂苷口腔崩解片制剂及其制备方法 | |
CN1297263C (zh) | 葡萄糖酸钙口腔崩解片及其制备工艺 | |
CN1267094C (zh) | 红花黄色素口腔崩解片及其制备工艺 | |
CN1254240C (zh) | 水飞蓟宾葡甲胺盐口腔崩解片及其制备工艺 | |
CN1742726A (zh) | 阿魏酸哌嗪口腔崩解片及其制备方法 | |
CN1660098A (zh) | 含有盐酸西替利嗪的口服药物组合物 | |
CN1895250A (zh) | 一种格列喹酮的缓释制剂 | |
CN1634014A (zh) | 阿魏酸钠口腔崩解片及其制备工艺 | |
CN1634066A (zh) | 盐酸阿夫唑嗪分散片 | |
CN1245163C (zh) | 葛根素分散片组合物及其制备方法 | |
CN1634390A (zh) | 刺五加口腔崩解片及其制备工艺 | |
CN1209109C (zh) | 阿昔莫司缓释片 | |
CN1296045C (zh) | 二氢麦角碱及其衍生物的口腔崩解片及其制备工艺 | |
CN1628655A (zh) | 穿心莲内酯分散片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LUNAN PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER OWNER: LUNAN PHARMACY CO. LTD. Effective date: 20050812 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050812 Address after: 276005 No. 209 Hongqi Road, Shandong, Linyi Applicant after: Lunan Pharmaceutical Group Co., Ltd. Address before: No. 107, Linxi, Linyi, Shandong Applicant before: Lunan Pharmacy Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Lunan Beite Pharmaceutical Co., Ltd. Assignor: Lunan Pharmaceutical Group Co., Ltd. Contract record no.: 2010370000513 Denomination of invention: Acipimox Dispersible tablet Granted publication date: 20061206 License type: Exclusive License Open date: 20050622 Record date: 20100909 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Lunan Beite Pharmaceutical Co., Ltd. Assignor: Lunan Pharmaceutical Group Co., Ltd. Contract record no.: 2010370000513 Date of cancellation: 20131016 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20050622 Assignee: Lunan Beite Pharmaceutical Co., Ltd. Assignor: Lunan Pharmaceutical Group Co., Ltd. Contract record no.: 2013370000265 Denomination of invention: Acipimox Dispersible tablet Granted publication date: 20061206 License type: Exclusive License Record date: 20131210 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model |